Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_08-cv-05590/USCOURTS-cand-5_08-cv-05590-36/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

 

STIPULATION AND [PROPOSED] ORDER REGARDING CASE SCHEDULE 

CASE NO. CV-08-5590 (JF) 

GERSON A. ZWEIFACH (admitted pro hac vice) 

PAUL B. GAFFNEY (admitted pro hac vice) 

DAVID I. BERL (No. 211761) 

JESSAMYN S. BERNIKER (admitted pro hac vice) 

THOMAS S. FLETCHER (No. 262693) 

WILLIAMS & CONNOLLY LLP 

725 Twelfth Street, NW 

Washington, DC 20005-5901 

Telephone: (202) 434-5000 

Facsimile: (202) 434-5029 

ELLIOT M. OLSTEIN (admitted pro hac vice) 

CARELLA, BYRNE, BAIN, GILFILLAN, 

CECCHI, STEWART & OLSTEIN, P.C. 

Five Becker Farm Road 

Roseland, NJ 07068-1739 

Telephone: (973) 994-1700 

Facsimile: (973) 994-1744 

JEFFREY E. FAUCETTE (No. 193066) 

TAYLOR & COMPANY 

Law Offices, LLP 

One Ferry Building, Suite 355 

San Francisco, CA 94111 

Telephone: (415) 788-8200 

Facsimile: (415) 788-8208 

Attorneys for Plaintiff MedImmune, LLC 

MATTHEW D. POWERS (Bar No. 

104795) 

VERNON M. WINTERS (Bar No. 

130128) 

GREGORY D. HULL (Bar No. 57367) 

WEIL, GOTSHAL & MANGES LLP 

Silicon Valley Office 

201 Redwood Shores Parkway 

Redwood Shores, CA 94065 

Telephone: (650) 802-3000 

Facsimile: (650) 802-3100 

T. RAY GUY (admitted pro hac vice) 

WEIL, GOTSHAL & MANGES LLP 

200 Crescent Court, Suite 300 

Dallas, TX 75201 

Telephone: (214) 746-7700 

Facsimile: (214) 746-7777 

DAVID I. GINDLER (Bar No. 117824) 

JASON G. SHEASBY (Bar No. 205455) 

IRELL & MANELLA LLP 

1800 Avenue of the Stars, Suite 900 

Los Angeles, CA 90067-4276 

Telephone: (310) 277-1010 

Facsimile: (310) 203-7199 

Attorneys for Defendant and 

Counterclaim-Plaintiff PDL BioPharma, 

Inc. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN JOSE DIVISION 

MEDIMMUNE, LLC, 

Plaintiff, 

v. 

PDL BIOPHARMA, INC., 

Defendant. 

 Case No.: CV-08-5590 (JF) 

STIPULATION AND [PROPOSED] ORDER 

REGARDING EXPERT SCHEDULE 

 Trial Date: January 21, 2011 

-----------------

Case 5:08-cv-05590-JF Document 724 Filed 08/06/10 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

 1 

STIPULATION AND [PROPOSED] ORDER REGARDING CASE SCHEDULE 

CASE NO. CV-08-5590 (JF) 

 WHEREAS, MedImmune, LLC and PDL BioPharma, Inc. (collectively “the parties”) 

have agreed to extend the deadline for the exchange of certain expert reports, and 

WHEREAS, the proposed extension of the deadlines for these expert reports will not 

impact the trial date or other deadlines in the case calendar: 

IT IS HEREBY STIPULATED AND AGREED by and between the parties that the expert 

report schedule be modified as set forth below. 

Event Date 

Parties’ expert reports (on issues first raised by First Amended Answer or 

responsive pleading thereto, for which a party bears the burden of proof). 

August 23, 2010 

Parties’ rebuttal expert reports. September 15, 2010 

IT IS FURTHER HEREBY STIPULATED AND AGREED by and between the parties 

that all expert depositions shall be completed by October 7, 2010, the current deadline for expert 

discovery. 

No other aspect of the case schedule is modified by this Stipulation and Order. 

DATED: August 3, 2010 Respectfully Submitted, 

 __/s/ Jessamyn S. Berniker_________ 

 Jessamyn S. Berniker 

 Attorney for Plaintiff, MedImmune LLC 

 __/s/ David I. Gindler______________ 

 David I. Gindler 

 Attorney for Defendant, PDL Biopharma, Inc. 

IT IS SO ORDERED. 

DATED: _________, 2010. 

 

The Honorable Jeremy Fogel 

United States District Judge 

8/3

Case 5:08-cv-05590-JF Document 724 Filed 08/06/10 Page 2 of 2